SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA (NCT07746570) | Clinical Trial Compass
CompletedNot Applicable
SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA
Turkey (Türkiye)26 participantsStarted 2026-01-02
Plain-language summary
Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups.
The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older.
* Diagnosed with asthma by a physician.
* A baseline Visual Analog Scale (VAS) score of 3 or higher for both dyspnea and insomnia.
* Receiving routine asthma treatment.
* Able to communicate in Turkish.
* Able to understand the study procedures and provide written informed consent.
* Willing to participate in the study.
Exclusion Criteria:
* Presence of severe cognitive or psychiatric disorders that could interfere with participation.
* Presence of skin lesions, infection, or injury on the hands that would prevent Su Jok therapy.
* Participation in another clinical trial during the study period.
* Withdrawal of consent at any stage of the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested Su Jok therapy — a form of hand and foot acupressure — for asthma-related breathlessness and sleep problems, so could you help me understand whether this kind of complementary approach is something worth exploring alongside my current asthma treatment, or whether it might interfere with anything I'm already taking?
2Since this trial has already been completed and its primary goal was measuring how much it reduced breathlessness severity, have the results been published anywhere, and what do they suggest about whether Su Jok therapy actually made a meaningful difference for people with asthma like me?
3Because this is listed as Phase NA — meaning it wasn't a standard drug trial with the usual Phase 1 through 3 safety testing — what does that mean for how confident we can be about the safety and effectiveness of Su Jok therapy based on this study alone?
4The trial also looked at insomnia alongside dyspnea, and I do struggle with sleep because of my asthma — do you think the findings from a study like this would be strong enough evidence to support me trying Su Jok therapy for both issues, or would you want to see more research first?
5Are there standard or evidence-based treatments for asthma-related breathlessness and sleep disruption that we haven't fully explored yet, and how would those compare to what a complementary therapy trial like this one was testing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Dyspnea severity
Timeframe: Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.